These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

137 related articles for article (PubMed ID: 5146732)

  • 21. Hepatotoxicity of antituberculosis therapy (rifampicin, isoniazid and pyrazinamide) or viral hepatitis.
    Türktaş H; Unsal M; Tülek N; Orüç O
    Tuber Lung Dis; 1994 Feb; 75(1):58-60. PubMed ID: 8161767
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Hepatitis induced by combined rifomycin and isoniazid].
    Marche J; Hugues FC; Graisely B; Marche C
    Ann Med Interne (Paris); 1971 Oct; 122(10):1045-54. PubMed ID: 5150725
    [No Abstract]   [Full Text] [Related]  

  • 23. [Cholestatic hepatitis during treatment with I.N.H. and rifampicin: arguments in favour of the hepatotoxicity of rifampicin (author's transl)].
    Poupon RY; Meyniel D; Petit J; Gustot P; Darnis F
    Ann Med Interne (Paris); 1979; 130(6-7):371-5. PubMed ID: 496138
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Determination of adverse reactions of chronic drug therapy as examplified with the hepatotoxic action of isoniazid and rifampicin].
    Bartmann K
    Verh Dtsch Ges Inn Med; 1977 Apr 17-21; 83():1518-29. PubMed ID: 347784
    [No Abstract]   [Full Text] [Related]  

  • 25. Predisposing factors in hepatitis induced by isoniazid-rifampin treatment of tuberculosis.
    Grönhagen-Riska C; Hellstrom PE; Fröseth B
    Am Rev Respir Dis; 1978 Sep; 118(3):461-6. PubMed ID: 707874
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Isoniazid-rifampicin: an exemplary hepatotoxicity].
    Berthelot P
    Gastroenterol Clin Biol; 1978 Feb; 2(2):129-32. PubMed ID: 640330
    [No Abstract]   [Full Text] [Related]  

  • 27. [Isoniazid-rifampicin: a model for hepatotoxicity and for bibliographic Anglomania].
    Toulet J; Viteau JM
    Gastroenterol Clin Biol; 1978; 2(8-9):756-7. PubMed ID: 361483
    [No Abstract]   [Full Text] [Related]  

  • 28. [Jaundice and rifampicin].
    Piéron R; Marien C; Jagueux M
    Sem Hop; 1971 Apr; 47(20):1286-95. PubMed ID: 4326532
    [No Abstract]   [Full Text] [Related]  

  • 29. Hepatotoxicity of rifampicin and isoniazid in children.
    Casteels-Van Daele M; Igodt-Ameye L; Corbeel L; Eeckels R
    J Pediatr; 1975 May; 86(5):739-41. PubMed ID: 1079531
    [No Abstract]   [Full Text] [Related]  

  • 30. Hepatitis from isoniazid and rifampin.
    Groopman JE; Soloff L; Tessler S
    N Engl J Med; 1978 Jun; 298(23):1316-7. PubMed ID: 651986
    [No Abstract]   [Full Text] [Related]  

  • 31. Jaundice associated with rifampicin.
    Hollins PJ; Simmons AV
    Tubercle; 1970 Sep; 51(3):328-32. PubMed ID: 5495656
    [No Abstract]   [Full Text] [Related]  

  • 32. [Hepatotoxicity of the rifampicin-isoniazid combination in children].
    Bonora G; De La Pierre L; Perletti L
    Minerva Pediatr; 1981 Aug; 33(16):835-6. PubMed ID: 7311946
    [No Abstract]   [Full Text] [Related]  

  • 33. [Role of isoniazid in hepatotoxicity with the INH-rifampicin combination in tuberculosis in children].
    Dieu MJ
    J Med Lyon; 1972 Oct; 53(234):1323-4 passim. PubMed ID: 4539047
    [No Abstract]   [Full Text] [Related]  

  • 34. [Synergistic effect of rifampicin on hepatotoxicity of isoniazid].
    Skakun NP; Shman'ko VV
    Antibiot Med Biotekhnol; 1985 Mar; 30(3):185-9. PubMed ID: 4015060
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Increase in transaminases and jaundice during treatment with rifampicin combined with isoniazid].
    Kreis B; Boutonnet G
    Rev Tuberc Pneumol (Paris); 1970 Dec; 34(8):1097-106. PubMed ID: 5517156
    [No Abstract]   [Full Text] [Related]  

  • 36. [Detection of the effects of the rifampin-isoniazid combination on the human liver].
    Plomteux G; Heusghem C; Ferdinande R; Lecoq A; Winandy A; Parmentier JC
    Nouv Presse Med; 1974 Mar; 3(12):727-32. PubMed ID: 4836506
    [No Abstract]   [Full Text] [Related]  

  • 37. [Report on 13 cases (including 3 deaths) of liver damage induced by rifampicin (author's transl)].
    Tong YY
    Zhonghua Jie He He Hu Xi Xi Ji Bing Za Zhi; 1980 Mar; 3(1):35-8. PubMed ID: 7428575
    [No Abstract]   [Full Text] [Related]  

  • 38. Isoniazid-rifampin fulminant hepatitis. A possible consequence of the enhancement of isoniazid hepatotoxicity by enzyme induction.
    Pessayre D; Bentata M; Degott C; Nouel O; Miguet JP; Rueff B; Benhamou JP
    Gastroenterology; 1977 Feb; 72(2):284-9. PubMed ID: 830577
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Histological study of hepatitis observed during treatment with rifampicin (comparison with the results of research on the Australia antigen)].
    Tuchais E; Pillot J; Simard C; Bertrand G; Oury M
    Rev Tuberc Pneumol (Paris); 1971 Mar; 35(2):185-96. PubMed ID: 5572017
    [No Abstract]   [Full Text] [Related]  

  • 40. Isoniazid-associated hepatitis. Report of an outbreak.
    Garibaldi RA; Drusin RE; Ferebee SH; Gregg MB
    Am Rev Respir Dis; 1972 Sep; 106(3):357-65. PubMed ID: 5080707
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.